Cefuzonam sodium
| Code | Size | Price |
|---|
| TAR-T23871-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Cefuzonam sodium is a second-generation cephalosporin antibiotic. It may be effective against Staphylococcus aureus against which third-generation cephalosporins are largely ineffective.
CAS:
82219-81-6
Formula:
C16H14N7NaO5S4
Molecular Weight:
535.56
Purity:
0.98
SMILES:
[Na+].CON=C(/C(=O)NC1C2SCC(CSc3cnns3)=C(N2C1=O)C([O-])=O)c1csc(N)n1
References
1. Inagaki K, Kambara M, Mizuno M, Okuda J, Gill MA, Nishida M. Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated y-site administration. Int J Pharm Compd. 1998 Jul-Aug;2(4):318-21. PubMed PMID: 23989642.
2. Kitano K, Shirao Y, Kawasaki K. Non-toxic concentrations of cephem antibiotics for intravitreal application--evaluation by in vitro electroretinogram. Ophthalmic Res. 1995;27 Suppl 1:128-35. PubMed PMID: 8577450.
3. Miyake Y, Okada M, Iseda S, Suginaka H. Effects of cefuzonam on peptidoglycan cross-linking reactions in gram-negative bacilli. Chemotherapy. 1992;38(1):17-20. PubMed PMID: 1617999.
4. Morita M, Aritomi H. Bone cement not weakened by cefuzonam powder. Acta Orthop Scand. 1991 Jun;62(3):232-7. PubMed PMID: 2042464.